stp_bannerlogocombo twitter facebook employee contact

Synergy Therapeutic Partners (STP) is a premier multi-centered clinical research organization that conducts highly efficient clinical trials for the pharmaceutical industry. "Our Vision is to provide best practices in clinical research for the advancement of modern day medicine." Our staff has a combined experience of 15 years offering the "We Care" attitude to our patients and stakeholders. We are committed to serving our communities with best practices and innovating ideas that will positively impact the medical industry.

Welcome to Synergy Therapeutic Partners

"Today’s Standard Treatment was Yesterday’s Clinical Trial"

Synergy Therapeutic Partners (STP) provides efficient and high quality Phase II, III, IV, and over-the-counter clinical trials to the pharmaceutical industry.  Our staff is committed to the advancement of modern medicine by providing our clients with reliable and expeditious services.  We serve as the connecting force in meeting and exceeding expectations in patient recruitment and regulatory processing.

lg_test_tubes

STP is committed to making clinical trials accessible across diverse populations and providing patients with optimal care.  We ensure each patient is well-informed about the clinical research process. Please feel free to view the FAQs to learn more about participating in a clinical trial.   

FDA Drug Info Rounds
Drug Name Review
FDA Drug Info Rounds pharmacists discuss FDA's ...

Communicating Benefit and ...
FDA Drug Info Rounds pharmacists talk about the ...

Communicating Drug Safety ...
FDA Drug Info Rounds pharmacists discuss the ...

Drug Shortages Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Evamist Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Proton Pump Inhibitors (PPIs) ...
FDA Drug Info Rounds pharmacists discuss new ...

Long-Acting Beta-Agonists ...
Long-Acting Beta-Agonists (LABAs), a class of ...

Single-Ingredient Oral ...
FDA Drug Info Rounds pharmacists discuss the ...

NIH News Releases
Despite risks, benzodiazepine ...
National Institutes of Health-supported study ...

NIH complementary and ...
The National Center for Complementary and ...

Update on Patient with ...
NIH continues to observe and monitor patient with ...

Study finds genetic clue to ...
NIH-funded research may also contribute to ...

Chronic high blood sugar may ...
NIH study shows young children with type 1 ...

Low-glycemic diets may not ...
Results of the study appear online in the Journal ...

Teen prescription opioid ...
However, NIH’s 2014 Monitoring the Future ...

NIH recruits three Lasker ...
Cohort for clinical research program continues to ...

UPDATE: Patient with exposure ...
Patient will be observed in the Clinical ...

Patient with exposure to ...
Patient will be observed in the Clinical ...

Chronic low-back pain ...
Better research may help address health issue ...

NIH initiates “Centers ...
Projects build a virtual center for research on ...

NIH funds robots to assist ...
Robots interact with patients to help in ...

NIH I-Corps entrepreneurial ...
Nineteen teams participating in the National ...

Researchers conduct ...
New data resource will enhance disease research ...

NIH researchers link ...
Duplication of gene on X chromosome appears to ...

Medications for patients with ...
Researchers call for more prescriber education ...

Barrier-breaking drug may ...
NIH-funded scientists take first step towards ...

NIH takes step to speed the ...
The draft NIH policy proposes that all NIH-funded ...

NIH statement on World AIDS ...
Remarkable progress has been made in the fight ...